Lawrence V. Friedrich

2.3k total citations
58 papers, 1.9k citations indexed

About

Lawrence V. Friedrich is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Lawrence V. Friedrich has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 26 papers in Molecular Medicine and 20 papers in Infectious Diseases. Recurrent topics in Lawrence V. Friedrich's work include Antibiotics Pharmacokinetics and Efficacy (35 papers), Antibiotic Resistance in Bacteria (26 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). Lawrence V. Friedrich is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (35 papers), Antibiotic Resistance in Bacteria (26 papers) and Antimicrobial Resistance in Staphylococcus (18 papers). Lawrence V. Friedrich collaborates with scholars based in United States, United Kingdom and South Africa. Lawrence V. Friedrich's co-authors include Roger L. White, John A. Bosso, Gregory E. Steinkraus, Kenneth C. Lamp, Charles R. Bonapace, Judith N. Steenbergen, Sujata M. Bhavnani, Paul G. Ambrose, Brian VanScoy and Rodrigo E. Mendes and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Clinical Microbiology.

In The Last Decade

Lawrence V. Friedrich

57 papers receiving 1.8k citations

Peers

Lawrence V. Friedrich

PHARM

EPIDE

Ellie Hershberger United States

Alison Meagher United States

Deborah C. Draghi United States

Francesco Cristini Italy

Christopher M. Rubino United States

Karen E. Bowker United Kingdom

Roger L. White United States

C H Nightingale United States

Jennifer M Streit United States

Laurent Massias France

Ellie Hershberger United States

Lawrence V. Friedrich

915 ×1.1

PHARM

1.1k ×1.4

966 ×1.4

764 ×1.3

EPIDE

651 ×1.2

Citations per year, relative to Lawrence V. Friedrich Lawrence V. Friedrich (= 1×) peers Ellie Hershberger

Countries citing papers authored by Lawrence V. Friedrich

Since Specialization

Citations

This map shows the geographic impact of Lawrence V. Friedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence V. Friedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence V. Friedrich more than expected).

Fields of papers citing papers by Lawrence V. Friedrich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence V. Friedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence V. Friedrich. The network helps show where Lawrence V. Friedrich may publish in the future.

Co-authorship network of co-authors of Lawrence V. Friedrich

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence V. Friedrich. A scholar is included among the top collaborators of Lawrence V. Friedrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence V. Friedrich. Lawrence V. Friedrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lakota, Elizabeth A., Sujata M. Bhavnani, Lawrence V. Friedrich, et al.. (2023). Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics. Antimicrobial Agents and Chemotherapy. 67(4). e0239721–e0239721. 6 indexed citations

Mohr, John, Lawrence V. Friedrich, Sara Yankelev, & Kenneth C. Lamp. (2009). Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE). International Journal of Antimicrobial Agents. 33(6). 543–548. 56 indexed citations

Sakoulas, George, Jack Brown, Kenneth C. Lamp, Lawrence V. Friedrich, & Kimberly C. Lindfield. (2009). Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience. Clinical Therapeutics. 31(9). 1936–1945. 46 indexed citations

Owens, Robert C., et al.. (2007). Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin. The American Journal of Medicine. 120(10). S6–S12. 30 indexed citations

Sakoulas, George, et al.. (2007). Daptomycin in the Treatment of Bacteremia. The American Journal of Medicine. 120(10). S21–S27. 39 indexed citations

Krige, J E J, Kimberly C. Lindfield, Lawrence V. Friedrich, et al.. (2007). Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections. Current Medical Research and Opinion. 23(9). 2147–2156. 16 indexed citations

Holtom, Paul, et al.. (2007). Clinical Experience with Daptomycin Treatment of Foot or Ankle Osteomyelitis. Clinical Orthopaedics and Related Research. 461. 35–39. 10 indexed citations

Rolston, Kenneth V. I., John Segreti, Kenneth C. Lamp, & Lawrence V. Friedrich. (2007). Cubicin Outcomes Registry and Experience (CORE) Methodology. The American Journal of Medicine. 120(10). S4–S5. 42 indexed citations

Lamp, Kenneth C., et al.. (2007). Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis. The American Journal of Medicine. 120(10). S13–S20. 80 indexed citations

10.

Bonapace, Charles R., Roger L. White, Lawrence V. Friedrich, & John A. Bosso. (2002). Differences in Antimicrobial Drug Exposure in Patients with Various Degrees of Renal Function Based on Recommendations from Dosing References. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(9). 1097–1104. 5 indexed citations

11.

Bonapace, Charles R., John A. Bosso, Lawrence V. Friedrich, & Roger L. White. (2002). Comparison of methods of interpretation of checkerboard synergy testing. Diagnostic Microbiology and Infectious Disease. 44(4). 363–366. 152 indexed citations

12.

White, Roger L., et al.. (2001). Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis. Diagnostic Microbiology and Infectious Disease. 39(1). 39–47. 10 indexed citations

13.

White, Roger L., et al.. (2001). Effect of removal of duplicate isolates on cumulative susceptibility reports. Diagnostic Microbiology and Infectious Disease. 39(4). 251–256. 23 indexed citations

14.

Bonapace, Charles R., Roger L. White, Lawrence V. Friedrich, & John A. Bosso. (2000). Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagnostic Microbiology and Infectious Disease. 38(1). 43–50. 110 indexed citations

15.

White, Roger L., et al.. (2000). Assessment of the Relationship between Antimicrobial Usage and Susceptibility: Differences between the Hospital and Specific Patient-Care Areas. Clinical Infectious Diseases. 31(1). 16–23. 54 indexed citations

16.

Friedrich, Lawrence V., Roger L. White, & John A. Bosso. (1999). Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram‐Negative Aerobes. Clinical Infectious Diseases. 28(5). 1017–1024. 48 indexed citations

17.

White, Roger L., et al.. (1994). The Costs of Burn Care: An Analysis With an Emphasis on the Use of Parenteral Antimicrobials. Journal of Burn Care & Rehabilitation. 15(3). 244–250. 12 indexed citations

18.

Kays, Meg, Roger L. White, Lawrence V. Friedrich, & Victor E. Del Bene. (1992). Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.. PubMed. 13(5). 596–605. 7 indexed citations

19.

Friedrich, Lawrence V., et al.. (1990). The Effect of Tourniquet Inflation on Cefazolin Tissue Penetration During Total Knee Arthroplasty. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(6). 373–377. 12 indexed citations

20.

Friedrich, Lawrence V., et al.. (1990). Pharmacokinetic evaluation of aztreonam in burn patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(3). 241. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact